Literature DB >> 28695995

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance.

Daniela Barraco1, Sonia Cerquozzi1, Curtis A Hanson2, Rhett P Ketterling3, Animesh D Pardanani1, Naseema Gangat1, Ayalew Tefferi1.   

Abstract

Entities:  

Keywords:  karyotype; myeloproliferative; polycythaemia; prognosis; survival

Mesh：

Year:  2017        PMID： 28695995     DOI： 10.1111/bjh.14798

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.

Authors:  Lukas Ronner; Nikolai Podoltsev; Jason Gotlib; Mark L Heaney; Andrew T Kuykendall; Casey O'Connell; Jamile Shammo; Angela G Fleischman; Robyn M Scherber; Ruben Mesa; Abdulraheem Yacoub; Cecelia Perkins; Shelby Meckstroth; Lindsey Behlman; Matthew Chiaramonte; Mahta Salehi; Kimia Ziadkhanpour; Hellen Nguyen; Olivia Siwoski; Annie Kwok Hung; Michelle Janania Martinez; Jenny Nguyen; Sagar Patel; Revathi Kollipara; Ami Dave; Megan Randall; Michael Grant; Mitchell Harrison; Paola Fernandez Soto; Douglas Tremblay; Ronald Hoffman; Erin Moshier; John Mascarenhas
Journal:  Blood       Date:  2020-05-07       Impact factor: 22.113

2.  Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.

Authors:  Barbara Mora; Toni Giorgino; Paola Guglielmelli; Elisa Rumi; Margherita Maffioli; Alessandro Rambaldi; Marianna Caramella; Rami Komrokji; Jason Gotlib; Jean Jacques Kiladjian; Francisco Cervantes; Timothy Devos; Francesca Palandri; Valerio De Stefano; Marco Ruggeri; Richard T Silver; Giulia Benevolo; Francesco Albano; Chiara Cavalloni; Daniela Barraco; Michele Merli; Daniela Pietra; Rosario Casalone; Tiziano Barbui; Giada Rotunno; Mario Cazzola; Alessandro Maria Vannucchi; Francesco Passamonti
Journal:  Haematologica       Date:  2018-04-05       Impact factor: 9.941

Review 3.  Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.

Authors:  Francesco Passamonti; Barbara Mora; Daniela Barraco; Margherita Maffioli
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 4.  Polycythemia vera treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

Review 5.  Polycythemia vera: historical oversights, diagnostic details, and therapeutic views.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Leukemia       Date:  2021-09-03       Impact factor: 11.528

6.  Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases.

Authors:  Naseema Gangat; Yamna Jadoon; Natasha Szuber; Curtis A Hanson; Alexandra P Wolanskyj-Spinner; Rhett P Ketterling; Animesh Pardanani; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2022-03-17       Impact factor: 11.037

Review 7.  Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms.

Authors:  Barbara Mora; Francesco Passamonti
Journal:  Curr Hematol Malig Rep       Date:  2022-09-01       Impact factor: 4.213

Review 8.  Is there a gender effect in polycythemia vera?

Authors:  Francesca Palandri; Barbara Mora; Naseema Gangat; Lucia Catani
Journal:  Ann Hematol       Date:  2020-10-02       Impact factor: 3.673
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.